factors affecting posology No Further a Mystery
Nevertheless, there is a minority of cases in which the therapy of EID using the ICOC chelation protocol involving DF or L1 or their mix will not be possible as a result of reduced tolerability or poisonous Unintended effects which include allergic reactions in the course of parenteral infusion of DF or toxicity for instance L1 agranulocytosis (Des